FDC Balance Sheet Annual

Trade

BSE: 531599 | NSE: FDC | ISIN: INE258B01022 | Sector: Biotechnology & Drugs

495.15 +6.25 (1.28%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	26.29	5.00	6.35	-
Short Term Investments	457.26	457.29	500.77	524.84
Cashand Short Term Investments	483.55	481.18	538.50	555.27
Accounts Receivable- Trade Net	117.38	122.83	82.31	111.07
Total Receivables Net	118.48	187.06	122.83	139.20
Total Inventory	388.89	346.19	328.50	226.27
Other Current Assets Total	75.57	3.60	1.83	5.31
Total Current Assets	1,066.49	1,026.91	1,000.19	933.75
Property/ Plant/ Equipment Total- Net	937.56	892.93	805.25	703.97
Intangibles Net	4.18	4.42	4.63	4.39
Long Term Investments	395.78	348.49	384.73	265.36
Note Receivable- Long Term	50.73	63.22	67.57	39.52
Other Long Term Assets Total	13.36	6.97	7.83	9.24
Total Assets	2,468.09	2,342.94	2,270.20	1,956.23
Accounts Payable	186.04	178.49	136.94	77.28
Current Portof LT Debt/ Capital Leases	7.94	7.52	6.92	7.14
Other Currentliabilities Total	116.65	74.45	82.05	83.75
Total Current Liabilities	310.62	311.56	272.16	204.00
Long Term Debt	0.25	0.56	0.65	0.21
Capital Lease Obligations	12.33	20.24	24.63	6.80
Total Long Term Debt	12.58	20.80	25.28	7.00
Total Debt	20.52	28.32	32.20	14.54
Deferred Income Tax	17.23	11.09	16.08	10.88
Minority Interest	0.00	-0.64	-0.43	-0.17
Other Liabilities Total	30.49	18.09	0.33	0.39
Total Liabilities	370.92	360.89	313.41	222.10
Common Stock Total	16.28	16.59	16.88	16.88
Retained Earnings( Accumulated Deficit)	2,080.89	1,955.21	1,929.98	1,712.45
Total Equity	2,097.17	1,982.05	1,956.79	1,734.13
Total Liabilities Shareholders' Equity	2,468.09	2,342.94	2,270.20	1,956.23
Total Common Shares Outstanding	16.28	16.59	16.88	16.88
Tangible Book Valueper Share Common Eq	128.55	119.20	115.64	102.47
Cash	-	18.89	31.38	30.43
Prepaid Expenses	-	8.88	8.53	7.71
Property/ Plant/ Equipment Total- Gross	-	1,159.22	1,036.58	900.53
Accumulated Depreciation Total	-	-266.29	-231.33	-196.57
Accrued Expenses	-	51.10	46.24	35.44
Notes Payable/ Short Term Debt	-	0.00	0.00	0.39
Other Equity Total	-	10.24	9.93	4.81